Israel Looks To Nurture New Leaders For Burgeoning Biotech Sector

Israeli Industry And Investment Leaders Discuss Market Development

While Israel has not wanted for early-stage scientific excellence, leading lights in the country's biotech space are working to create an ecosystem where clinical, regulatory and managerial expertise can develop.

Israel's life sciences sector is celebrated for its academic excellence and extensive basic R&D coming out of the likes of world-renowned establishments such as the Weizmann Institute and the Hebrew University of Jerusalem. There has historically been a lack of homegrown leadership to establish companies that can bridge the gap between discovery and getting products into late-stage trials, but this it is changing.

Someone well-equipped to see how the sector is developing and how companies are being created is Anat Naschitz, a managing director at health care investment firm OrbiMed, which is currently...

More from Growth

More from In Vivo